#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Waldenstrom's macroglobulinaemia recurrent Giant cell tumour of tendon sheath Infertility male Hyperadrenocorticism Follicular lymphoma stage III Cardiac failure acute Acquired ATTR amyloidosis Orthostatic hypotension Autoimmune disorder Angiosarcoma Focal segmental glomerulosclerosis Non-renal cell carcinoma of kidney Osteosarcoma metastatic Cataract Porphyria non-acute More trials…

    Learn about Rare Diseases

    Aicardi-Goutieres syndrome – Life with Disease Arterial tortuosity syndrome Mucopolysaccharidosis III – Basic Information Atypical haemolytic uraemic syndrome MELAS syndrome – Treatment Leukoencephalopathy – Trials in Disease Activated PI3 kinase delta syndrome – Trials in Disease Lysosomal storage disorder – Treatment Soft tissue sarcoma – Diagnostics Antithrombin III deficiency – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Elamipretide Trihydrochloride Midazolam DUVELISIB Donepezil Hydrochloride RP3 Kbp-336 Specific Nucleic Acid Sna-Xfsa Water For Injections Elexacaftor Idelalisib Alanine Anthoxanthum Odoratum Efpegerglucagon Poractant Alfa Clomifene Citrate Codeine Phosphate Lna043 BUMETANIDE GEN1078 BMS-986365 More therapies…

    Learn about Your Condition

    Heart disease congenital Inclusion body myositis HER2 negative breast cancer Idiopathic pulmonary fibrosis Non-small cell lung cancer Femur fracture Neonatal hyperglycaemia Acromegaly Nephroblastoma Hepatitis D Red blood cell abnormality Viral myocarditis Staphylococcal bacteraemia Antisynthetase syndrome Bacterial prostatitis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study testing Wharton’s jelly-derived mesenchymal stem cells with spinal cord stimulation for adults with chronic spinal cord injury

    Recruiting

    1 1 1
    Investigated Diseases:
    • Spinal cord injury
    Investigated Drugs:
    • ALLOGENEIC VIABLE WHARTON’S JELLY-DERIVED MESENCHYMAL STEM CELLS, EX-VIVO EXPANDED
    Spain

  • A Study of Tulmimetostat and Luxdegalutamide Compared to Standard Treatment in Men with Advanced Prostate Cancer That No Longer Responds to Hormone Therapy

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Hormone-refractory prostate cancer
    Investigated Drugs:
    • Tulmimetostat
    • LUXDEGALUTAMIDE
    • Cabazitaxel
    Denmark France Germany Italy Poland Spain

  • A Study of Acoramidis in Adult Patients with Transthyretin Amyloidosis with Cardiomyopathy Who Previously Received Tafamidis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Cardiac amyloidosis
    Investigated Drugs:
    • Acoramidis
    Austria Belgium Germany Italy

  • A Study of Venetoclax in People with HIV-1 Infection Starting Antiretroviral Treatment to Reduce the HIV Reservoir

    Recruiting

    1 1 1 1
    Investigated Drugs:
    • Venetoclax
    Denmark Spain

  • A study testing xanomeline tartrate and trospium chloride added to current treatment for adults with bipolar I disorder experiencing mania

    Recruiting

    3 1
    Investigated Diseases:
    • Bipolar I disorder
    Investigated Drugs:
    • Trospium Chloride
    • Xanomeline Tartrate
    Bulgaria Denmark France Italy Poland Romania

  • A Study of PTX-100 for Patients with Cutaneous T-Cell Lymphoma That Has Returned or Did Not Respond to Previous Treatment

    Recruiting

    2 1 1
    Investigated Diseases:
    • Cutaneous T-cell lymphoma recurrent
    • Cutaneous T-cell lymphoma refractory
    France Italy
Previous Page
1 … 92 93 94 95 96 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!